Learn More
Apexbio Technology LLC BRD4770 1374601-40-7 10mg

Supplier: Apexbio Technology LLC B483710
BRD4770 (CAS 1374601-40-7) is a small-molecule inhibitor targeting the histone methyltransferase G9a with an IC50 of 6 3 M In studies using the PANC-1 pancreatic cancer cell line BRD4770 was shown to decrease levels of di- and trimethylated histone H3 lysine 9 (H3K9) through inhibition of G9a activity This reduction in H3K9 methylation is associated with the induction of cellular senescence and cell death as well as suppression of both adherent-dependent and independent cell proliferation BRD4770 serves as a useful probe for exploring the epigenetic regulation of gene expression and cellular senescence in cancer biology research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.